Novel, potent, selective, and brain penetrant phosphodiesterase 10A inhibitors.Geneste, H., Drescher, K., Jakob, C., Laplanche, L., Ochse, M., Torrent, M.
(2019) Bioorg Med Chem Lett 29: 406-412
- PubMed: 30587449
- DOI: https://doi.org/10.1016/j.bmcl.2018.12.029
- Primary Citation of Related Structures:
- PubMed Abstract:
Herein we report the discovery of a novel series of phosphodiesterase 10A inhibitors. Optimization of a HTS hit (17) resulted in potent, selective, and brain penetrant 23 and 26; both exhibited much lower clearance in vivo and decreased volume of distribution (rat PK) and have thus the potential to inhibit the PDE10A target in vivo at a lower efficacious dose than the reference compound WEB-3.
AbbVie, Structural Biology, IL 60064-6101, USA.